BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BSGCT - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BSGCT
X-ORIGINAL-URL:https://bsgct.org
X-WR-CALDESC:Events for BSGCT
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20250312T183000
DTEND;TZID=UTC:20250312T193000
DTSTAMP:20250312T143752Z
CREATED:20250304T102156Z
LAST-MODIFIED:20250312T143752Z
UID:10000003-1741804200-1741807800@bsgct.org
SUMMARY:Public & Patient Series - Liver directed lentiviral gene therapy for inherited cholestatic disorders
DESCRIPTION:Approximately 1 in 2500 neonates develop cholestatic jaundice\, often due to rare genetic disorders with no cure and severe morbidity. This talk will explore how innovative lentiviral gene therapies could transform treatment\, using ARC syndrome as a case study. We will highlight key breakthroughs in optimizing gene delivery and ensuring vector safety— crucial steps toward life-changing therapies. \nDr Claudiu Cozmescu is a postdoctoral researcher in the Genetics and Genomic Medicine Research Teaching Department at the UCL Institute of Child Health\, focused on advancing in vivo lentiviral gene therapy for inherited liver and multi-organ disorders. He leads cutting-edge projects\, including “Multi-organ lentiviral gene therapy for ARC Syndrome\,” funded by LifeArc\, and has secured funding from Action Medical Research and the National Institute for Health and Care Research as PI and Co-PI to develop novel treatments for related genetic conditions. With a strong background in gene therapy and genetic technologies\, Dr Cozmescu’s work bridges innovative research with real-world clinical applications. He also helps shape the next generation of scientists as Co-Lead of two MSc core modules at the UCL Institute of Child Health: “Molecular Aspects of Cell and Gene Therapy” and “Clinical Applications of Cell and Gene Therapy.” \nFREE REGISTRATION \nPlease note the joining link will be emailed to you prior to the start of this event.
URL:https://bsgct.org/event/public-patient-series-liver-directed-lentiviral-gene-therapy-for-inherited-cholestatic-disorders/
CATEGORIES:Online Seminars,Patient and Public Engagement
ATTACH;FMTTYPE=image/png:https://bsgct.org/wp-content/uploads/2025/03/BSGCT-PostcardsYT-Thumbnails.png
LOCATION:https://bsgct.org/event/public-patient-series-liver-directed-lentiviral-gene-therapy-for-inherited-cholestatic-disorders/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250221T130000
DTEND;TZID=UTC:20250221T140000
DTSTAMP:20250221T115914Z
CREATED:20250213T150553Z
LAST-MODIFIED:20250221T115914Z
UID:10000002-1740142800-1740146400@bsgct.org
SUMMARY:Gene therapy for neuromuscular conditions
DESCRIPTION:BSGCT’s next Research Seminar will take place on Friday 21st of February 2025. Our Research Seminars are online sessions for researchers to focus on and discuss the latest developments in gene and cell therapy. The seminars are free to attend\, and take place live and online. \nWe are thrilled to have Dr. Alberto Malerba as our next guest speaker\, presenting his work on gene therapies for neuromuscular conditions.
URL:https://bsgct.org/event/gene-therapy-for-neuromuscular-conditions/
LOCATION:Online
CATEGORIES:Online Seminars,Research Webinars
ATTACH;FMTTYPE=image/png:https://bsgct.org/wp-content/uploads/2025/02/image006.png
END:VEVENT
END:VCALENDAR